AbbVie Inc. Other Nonoperating Income (Expense)
AbbVie Inc. (ABBV) reported Other Nonoperating Income (Expense) of -$1.48 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-03
- AbbVie Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$1.48B.
- AbbVie Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$2.31B.
- AbbVie Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$1.21B.
- AbbVie Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$503.00M.
- AbbVie Inc. other nonoperating income (expense) for fiscal 2025 was -$5.79B.
- AbbVie Inc. other nonoperating income (expense) for fiscal 2024 was -$3.24B.
- AbbVie Inc. other nonoperating income (expense) for fiscal 2023 was -$4.68B.
- AbbVie Inc. other nonoperating income (expense) for fiscal 2022 was -$2.45B.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.48B 10-Q · filed 2026-08-03 | -$3.78B 10-Q · filed 2026-08-03 | -$4.99B derived: sum of 3 quarters · filed 2026-08-03 | -$5.49B derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | -$2.31B 10-Q · filed 2026-05-08 | -$3.52B derived: sum of 2 quarters · filed 2026-05-08 | -$4.02B derived: sum of 3 quarters · filed 2026-05-08 | -$6.68B derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | -$1.21B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$1.71B derived: sum of 2 quarters · filed 2026-02-20 | -$4.38B derived: sum of 3 quarters · filed 2026-08-03 | -$5.79B 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | -$503.00M 10-Q · filed 2025-11-04 | -$3.17B derived: sum of 2 quarters · filed 2026-08-03 | -$4.58B 10-Q · filed 2025-11-04 | -$4.76B derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | -$2.66B 10-Q · filed 2026-08-03 | -$2.64B 10-Q · filed 2025-08-04 | -$4.11B 10-Q · filed 2026-08-03 | -$4.08B 10-Q · filed 2025-08-04 | -$4.26B derived: sum of 3 quarters · filed 2026-08-03 | -$5.42B derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | -$1.45B 10-Q · filed 2026-05-08 | -$1.44B 10-Q · filed 2025-05-09 | -$1.59B derived: sum of 2 quarters · filed 2026-05-08 | -$2.75B derived: sum of 3 quarters · filed 2026-05-08 | -$4.10B derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -$150.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$1.31B derived: sum of 2 quarters · filed 2026-02-20 | -$2.65B derived: sum of 3 quarters · filed 2026-02-20 | -$3.24B 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | -$1.16B 10-Q · filed 2025-11-04 | -$2.50B derived: sum of 2 quarters · filed 2025-11-04 | -$3.09B 10-Q · filed 2025-11-04 | -$4.65B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-06-30 | -$1.34B 10-Q · filed 2025-08-04 | -$1.93B 10-Q · filed 2025-08-04 | -$3.49B derived: sum of 3 quarters · filed 2026-02-20 | -$3.39B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-03-31 | -$586.00M 10-Q · filed 2025-05-09 | -$2.14B derived: sum of 2 quarters · filed 2026-02-20 | -$2.05B derived: sum of 3 quarters · filed 2026-02-20 | -$3.46B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | -$1.56B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$1.46B derived: sum of 2 quarters · filed 2026-02-20 | -$2.87B derived: sum of 3 quarters · filed 2026-02-20 | -$4.68B 10-K · filed 2026-02-20 | ||||
| 2023-09-30 | $95.00M 10-Q · filed 2024-11-04 | -$1.32B derived: sum of 2 quarters · filed 2024-11-04 | -$3.12B 10-Q · filed 2024-11-04 | -$5.14B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-06-30 | -$1.41B 10-Q · filed 2024-08-07 | -$3.22B 10-Q · filed 2024-08-07 | -$5.24B derived: sum of 3 quarters · filed 2025-02-14 | -$4.91B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-03-31 | -$1.80B 10-Q · filed 2024-05-03 | -$3.83B derived: sum of 2 quarters · filed 2025-02-14 | -$3.50B derived: sum of 3 quarters · filed 2025-02-14 | -$5.03B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2022-12-31 | -$2.02B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$1.69B derived: sum of 2 quarters · filed 2025-02-14 | -$3.22B derived: sum of 3 quarters · filed 2025-02-14 | -$2.45B 10-K · filed 2025-02-14 | ||||
| 2022-09-30 | $330.00M 10-Q · filed 2023-11-06 | -$1.20B derived: sum of 2 quarters · filed 2023-11-06 | -$427.00M 10-Q · filed 2023-11-06 | -$643.00M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | -$1.53B 10-Q · filed 2023-08-07 | -$757.00M 10-Q · filed 2023-08-07 | -$973.00M derived: sum of 3 quarters · filed 2024-02-20 | -$994.00M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | $776.00M 10-Q · filed 2023-05-05 | $560.00M derived: sum of 2 quarters · filed 2024-02-20 | $539.00M derived: sum of 3 quarters · filed 2024-02-20 | -$2.12B derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | -$216.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$237.00M derived: sum of 2 quarters · filed 2024-02-20 | -$2.90B derived: sum of 3 quarters · filed 2024-02-20 | -$2.50B 10-K · filed 2024-02-20 | ||||
| 2021-09-30 | -$21.00M 10-Q · filed 2022-11-04 | -$2.68B derived: sum of 2 quarters · filed 2022-11-04 | -$2.28B 10-Q · filed 2022-11-04 | -$6.91B derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-06-30 | -$2.66B 10-Q · filed 2022-08-04 | -$2.26B 10-Q · filed 2022-08-04 | -$6.89B derived: sum of 3 quarters · filed 2023-02-17 | -$7.00B derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-03-31 | $395.00M 10-Q · filed 2022-05-06 | -$4.23B derived: sum of 2 quarters · filed 2023-02-17 | -$4.34B derived: sum of 3 quarters · filed 2023-02-17 | -$5.15B derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2020-12-31 | -$4.63B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | -$4.74B derived: sum of 2 quarters · filed 2023-02-17 | -$5.54B derived: sum of 3 quarters · filed 2023-02-17 | -$5.61B 10-K · filed 2023-02-17 | ||||
| 2020-09-30 | -$115.00M 10-Q · filed 2021-11-02 | -$917.00M derived: sum of 2 quarters · filed 2021-11-02 | -$989.00M 10-Q · filed 2021-11-02 | -$1.41B derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-06-30 | -$802.00M 10-Q · filed 2021-08-02 | -$874.00M 10-Q · filed 2021-08-02 | -$1.29B derived: sum of 3 quarters · filed 2022-02-18 | -$1.47B derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-03-31 | -$72.00M 10-Q · filed 2021-05-07 | -$488.00M derived: sum of 2 quarters · filed 2022-02-18 | -$665.00M derived: sum of 3 quarters · filed 2022-02-18 | -$2.94B derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2019-12-31 | -$416.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | -$593.00M derived: sum of 2 quarters · filed 2022-02-18 | -$2.87B derived: sum of 3 quarters · filed 2022-02-18 | -$3.01B 10-K · filed 2022-02-18 | ||||
| 2019-09-30 | -$177.00M 10-Q · filed 2020-11-04 | -$2.46B derived: sum of 2 quarters · filed 2020-11-04 | -$2.59B 10-Q · filed 2020-11-04 | -$2.20B derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | -$2.28B 10-Q · filed 2020-08-04 | -$2.41B 10-Q · filed 2020-08-04 | -$2.02B derived: sum of 3 quarters · filed 2021-02-19 | -$2.11B derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | -$135.00M 10-Q · filed 2020-05-08 | $258.00M derived: sum of 2 quarters · filed 2021-02-19 | $164.00M derived: sum of 3 quarters · filed 2021-02-19 | -$306.00M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | $393.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $299.00M derived: sum of 2 quarters · filed 2021-02-19 | -$171.00M derived: sum of 3 quarters · filed 2021-02-19 | -$18.00M 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | -$94.00M 10-Q · filed 2019-11-06 | -$564.00M derived: sum of 2 quarters · filed 2019-11-06 | -$411.00M 10-Q · filed 2019-11-06 | -$428.00M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | -$470.00M 10-Q · filed 2019-08-05 | -$317.00M 10-Q · filed 2019-08-05 | -$334.00M derived: sum of 3 quarters · filed 2020-02-21 | -$672.00M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | $153.00M 10-Q · filed 2019-05-03 | $136.00M derived: sum of 2 quarters · filed 2020-02-21 | -$202.00M derived: sum of 3 quarters · filed 2020-02-21 | -$252.00M derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | -$17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$355.00M derived: sum of 2 quarters · filed 2020-02-21 | -$405.00M derived: sum of 3 quarters · filed 2020-02-21 | -$466.00M 10-K · filed 2020-02-21 | -$513.00M 10-K · filed 2018-02-16 | |||
| 2017-09-30 | -$338.00M 10-Q · filed 2018-11-07 | -$349.00M 10-Q · filed 2017-11-07 | -$388.00M derived: sum of 2 quarters · filed 2018-11-07 | -$449.00M 10-Q · filed 2018-11-07 | -$484.00M 10-Q · filed 2017-11-07 | -$485.00M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-06-30 | -$50.00M 10-Q · filed 2018-08-07 | -$62.00M 10-Q · filed 2017-08-07 | -$111.00M 10-Q · filed 2018-08-07 | -$135.00M 10-Q · filed 2017-08-07 | -$147.00M derived: sum of 3 quarters · filed 2019-02-27 | -$248.00M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-03-31 | -$61.00M 10-Q · filed 2018-05-04 | -$73.00M 10-Q · filed 2017-05-05 | -$97.00M derived: sum of 2 quarters · filed 2019-02-27 | -$198.00M derived: sum of 3 quarters · filed 2019-02-27 | -$249.00M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2016-12-31 | -$36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$137.00M derived: sum of 2 quarters · filed 2019-02-27 | -$188.00M derived: sum of 3 quarters · filed 2019-02-27 | -$188.00M 10-K · filed 2019-02-27 | -$232.00M 10-K · filed 2017-02-17 | |||
| 2016-09-30 | -$101.00M 10-Q · filed 2017-11-07 | -$152.00M derived: sum of 2 quarters · filed 2017-11-07 | -$152.00M 10-Q · filed 2017-11-07 | -$140.00M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | -$51.00M 10-Q · filed 2017-08-07 | -$51.00M 10-Q · filed 2017-08-07 | -$39.00M derived: sum of 3 quarters · filed 2018-02-16 | -$67.00M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-05 | $12.00M derived: sum of 2 quarters · filed 2018-02-16 | -$16.00M derived: sum of 3 quarters · filed 2018-02-16 | -$12.00M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2015-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$16.00M derived: sum of 2 quarters · filed 2018-02-16 | -$12.00M derived: sum of 3 quarters · filed 2018-02-16 | -$13.00M 10-K · filed 2018-02-16 | ||||
| 2015-09-30 | -$28.00M 10-Q · filed 2016-11-07 | -$24.00M derived: sum of 2 quarters · filed 2016-11-07 | -$25.00M 10-Q · filed 2016-11-07 | -$22.00M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $4.00M 10-Q · filed 2016-08-05 | $3.00M 10-Q · filed 2016-08-05 | $6.00M derived: sum of 3 quarters · filed 2017-02-17 | $35.00M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | -$1.00M 10-Q · filed 2016-05-06 | $2.00M derived: sum of 2 quarters · filed 2017-02-17 | $31.00M derived: sum of 3 quarters · filed 2017-02-17 | $23.00M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $32.00M derived: sum of 2 quarters · filed 2017-02-17 | $24.00M derived: sum of 3 quarters · filed 2017-02-17 | $27.00M 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $29.00M 10-Q · filed 2015-11-06 | $21.00M derived: sum of 2 quarters · filed 2015-11-06 | $24.00M 10-Q · filed 2015-11-06 | $11.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | -$8.00M 10-Q · filed 2015-08-07 | -$5.00M 10-Q · filed 2015-08-07 | -$18.00M derived: sum of 3 quarters · filed 2016-02-19 | -$23.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $3.00M 10-Q · filed 2015-05-08 | -$10.00M derived: sum of 2 quarters · filed 2016-02-19 | -$15.00M derived: sum of 3 quarters · filed 2016-02-19 | -$11.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | -$13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$18.00M derived: sum of 2 quarters · filed 2016-02-19 | -$14.00M derived: sum of 3 quarters · filed 2016-02-19 | $1.00M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | -$5.00M 10-Q · filed 2014-11-07 | -$1.00M derived: sum of 2 quarters · filed 2014-11-07 | $14.00M 10-Q · filed 2014-11-07 | -$16.00M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2013-06-30 | $4.00M 10-Q · filed 2014-08-07 | $19.00M 10-Q · filed 2014-08-07 | -$11.00M derived: sum of 3 quarters · filed 2015-02-20 | $2.00M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2013-03-31 | $15.00M 10-Q · filed 2014-05-09 | -$15.00M derived: sum of 2 quarters · filed 2015-02-20 | -$2.00M derived: sum of 3 quarters · filed 2015-02-20 | -$13.00M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2012-12-31 | -$30.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | -$17.00M derived: sum of 2 quarters · filed 2015-02-20 | -$28.00M derived: sum of 3 quarters · filed 2015-02-20 | $9.00M 10-K · filed 2015-02-20 | ||||
| 2012-09-30 | $13.00M 10-Q · filed 2013-11-12 | $2.00M derived: sum of 2 quarters · filed 2013-11-12 | $39.00M 10-Q · filed 2013-11-12 | |||||
| 2012-06-30 | -$11.00M 10-Q · filed 2013-08-09 | $26.00M 10-Q · filed 2013-08-09 | ||||||
| 2012-03-31 | $37.00M 10-Q · filed 2013-05-08 | |||||||
| 2011-12-31 | -$2.00M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |